Octapharma Research Site

11405 87 Avenue
Edmonton, Alberta T6G 1C9

We've found

1 trials

at this facility

Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Edmonton,

Use our guide to learn which trials are right for you!